Annals of Clinical Cancer and Therapy (ACCT) is a peer reviewed journal serving the International Scientific Community. This journal offers an open access platform to the authors to publish their research outcome and thus help in promoting Cancer and Oncology research.
ACCT is an Open Access publishing that aims to focus on the most complete and reliable source of information on discoveries and current developments as original article, review articles, case reports, short communications, etc. related to Cancer research and therapy and provides free online access to the researchers worldwide.
Cancer seeks to impart highly relevant and timely information to a broad audience of oncology and related specialists in the field. Cancer accomplishes this objective by publishing original and review articles that facilitate the transfer of knowledge from the laboratory to the bedside; contribute to cancer prevention, early detection, diagnosis, cure, and rehabilitation; and diminish suffering from cancer. Cancer also publishes educational supplements on various topics that are of interest to a broad oncology audience.
Major subject areas of interest in cancer include, Molecular and cellular mechanisms of cancer, Mechanisms for the sensitivity and the resistance to cancer therapies and development of better cancer therapies, Cancer genetics, Cancer cytology, Cancer pathology, Gynaecologic cancer, Ovarian cancer, Clinical aspects of cancer, Liver cancer, Lung cancer, Cancer endocrinology, Genitourinary cancer, Colorectal cancer, Bone cancer, Prostate cancer, Benign tumours, Cancer chemotherapy, Pediatric oncology, Cancer prevention, Recent developments in tumor therapy, Radiation oncology, Apoptosis, Oncogenes, Angiogenesis, Metastasis, Cancer image and interventional diagnosis and therapy, Tumor markers, Chemotherapy, Radiotherapy and biotherapy, Veterinary and Comparative oncology, Clinical trials in oncology, Cancer nanotechnology, Carcinoma, Sarcoma, Myeloma, Leukemia, Lymphoma.
Submit manuscript at Link or send as an e-mail attachment to the Editorial Office at cancer@researchnovelty.com
